Enrique Grande MD, PhD, MD Anderson Cancer Centre Madrid, Madrid, Spain, gives an overview of the key players in neuroendocrine tumor (NET) research in Europe. Dr Grande also highlights Phase III trials underway from the European Neuroendocrine Tumor Society (ENETS) to generate more data about the management of patients with G1 and G2 metastases. This interview took place during the European Neuroendocrine Tumor Society (ENETS) 19th Annual Conference 2021.